Insider Stock Trading History of Soffer Gad


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Soffer Gad since year 2005. The trader's CIK number is 1612090. At the time of this reporting, Soffer Gad is the EVP & Chief Strategy Officer of Atara Biotherapeutics, Inc. . (stock ticker symbol ATRA). See this page for all insider trading activities at Atara Biotherapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Soffer Gad since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-15 ATRA Atara Biotherapeutics, Inc. Option Ex 13,762 .00 0
2017-02-14 ATRA Atara Biotherapeutics, Inc. Sale 7,000 15.22 106,540
2017-02-16 ATRA Atara Biotherapeutics, Inc. Sale 7,273 15.62 113,604
2017-02-10 ATRA Atara Biotherapeutics, Inc. Sale 6,274 15.78 98,972
2016-11-17 ATRA Atara Biotherapeutics, Inc. Sale 1,480 18.41 27,246
2016-11-14 ATRA Atara Biotherapeutics, Inc. Sale 9,582 20.55 196,910
2016-11-15 ATRA Atara Biotherapeutics, Inc. Option Ex 13,761 .00 0
2016-11-16 ATRA Atara Biotherapeutics, Inc. Sale 7,136 19.27 137,510
2016-08-15 ATRA Atara Biotherapeutics, Inc. Option Ex 13,761 .00 0
2016-08-16 ATRA Atara Biotherapeutics, Inc. Sale 5,356 21.70 116,198
2016-05-16 ATRA Atara Biotherapeutics, Inc. Option Ex 13,761 .00 0
2016-05-17 ATRA Atara Biotherapeutics, Inc. Sale 5,427 15.91 86,343
2016-02-16 ATRA Atara Biotherapeutics, Inc. Option Ex 13,761 .00 0
2016-02-17 ATRA Atara Biotherapeutics, Inc. Sale 5,711 16.60 94,802
2015-11-17 ATRA Atara Biotherapeutics, Inc. Sale 7,586 31.39 238,139
2015-11-16 ATRA Atara Biotherapeutics, Inc. Option Ex 13,762 .00 0
2015-08-18 ATRA Atara Biotherapeutics, Inc. Sale 7,711 49.52 381,848
2015-08-17 ATRA Atara Biotherapeutics, Inc. Option Ex 16,538 3.67 60,644
2015-08-17 ATRA Atara Biotherapeutics, Inc. Sale 8,778 50.00 438,900
2015-05-15 ATRA Atara Biotherapeutics, Inc. Option Ex 102,239 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Soffer Gad (EVP & Chief Strategy Officer of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.